
Evaluating anticancer potentials of potentized preparations in an in-vivo xenograft model
Background: Xenografts in immunodeficient mice play a pivotal role in testing novel anti-cancer treatments. Xenograft models expedite the drug discovery process, offering a cost-effective alternative



















